Navigation Links
Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
Date:7/30/2008

Clinical Program Leverages Quark's RNAi Technology

FREMONT, Calif., July 30 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that its partner, Pfizer Inc, initiated patient dosing in a Phase II trial evaluating

PF-4523655 (RTP801i-14) in patients with diabetic macular edema (DME).

PF-4523655 is a novel siRNA drug candidate being co-developed by Quark and Pfizer. As part of the companies' Global Licensing Agreement, the successful commencement of the trial triggers a milestone payment to Quark from Pfizer, a small percentage of which is payable by Quark to Silence Therapeutics and Alnylam as technology license milestone payments.

The Phase II prospective, randomized, dose-ranging study is evaluating the safety and efficacy of PF-4523655 versus laser therapy in 160 DME patients at multiple centers worldwide. PF-4523655 was designed to inhibit Quark's proprietary target RTP801, a gene involved in abnormal blood vessel development and leakage in the eye. Under the companies' Global Licensing Agreement, Pfizer has exclusive development rights to siRNA-mediated therapies that inhibit RTP801 for ophthalmic and non-ophthalmic indications, while Quark is eligible for development and sales based milestone payments.

Elena Feinstein, Chief Scientific Officer of Quark, commented, "By targeting the RTP801 gene, PF-4523655 is differentiated from other therapeutics for the same ophthalmic indications. While many competitors target VEGF and its receptors, PF-4523655 inhibits abnormal blood vessel growth and leakage independently of the VEGF pathway, reduces inflammation and suppresses apoptosis. Therefore,

PF-4523655 is a siRNA therapeutic candidate with the potential to be efficacious when used as a monotherapy and in combination with existing VEGF-based therapies."

Shai Erlich, Chief Development
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
2. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
3. Quark Pharmaceuticals Appoints New Chief Medical Officer
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
8. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
9. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
10. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
11. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 BioStructures, LLC ... American Association of Tissue Banks (AATB), it was ... Executive Officer. Accreditation follows an intensive ... specially trained AATB inspector.  It establishes that the ... the facility meets or exceeds the standards set ...
(Date:9/30/2014)... , Sept. 30, 2014  Proteomics is a ... a new report from Kalorama Information.  The healthcare market ... occurred in proteomics in the past two years.  ... agreements between private proteomic companies and academic institutions, ... novel proteomics innovator companies.  Kalorama observed the industry ...
(Date:9/30/2014)... , September 30, 2014 ... the CSF (Cerebrospinal Fluid) backflow of the Eldor spinal ... of the single hole pencil point spinal needles of ... Braun. Spinal anesthesia is an excellent type ... Orthopedics, Urology, General Anesthesia, etc. It is ...
Breaking Medicine Technology:Biostructures, LLC Earns AATB Accreditation 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3
... YORK, March 28, 2011 Havas Drive, the innovation ... of patient-centric services geared toward persons with disabilities and ... Smith—a nationally recognized authority on Web accessibility with a ... Pentagon Library, Kent State,s Knowledge Management program and the ...
... Inc. (Nasdaq: KERX ) (the "Company") today ... presented at the upcoming 102nd annual meeting of the ... in Orlando, Florida, from April 2-6, 2011. Perifosine, the ... Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, is ...
Cached Medicine Technology:Havas Drive Launches New Services Aimed at Improving Digital and Web Accessibility 2Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting 2Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting 3
(Date:9/30/2014)... to slow the spiraling costs of drugs paid for ... had no meaningful impact on cancer chemotherapy drug costs, ... of Clinical Oncology published online today. , "We ... and lung cancers, and did not find a substantial ... implementation of the recent Medicare law in 2005," says ...
(Date:9/30/2014)... by UC Irvine immunologists reveals new information about how ... process that determines how the body,s ability to fight ... Nature Immunology , neurology professor Dr. Michael Demetriou, postdoctoral ... describe a critical mechanism underlying how T cells are ... T cell is a type of blood cell called ...
(Date:9/30/2014)... 2014 Fat Burning Kitchen , the ... author Mike Geary that is helping people learn the truth ... a fat-burning machine in less than 24 hours has caught ... , “In our culture that is becoming so obsessed with ... what is really fact and fiction when it comes to ...
(Date:9/30/2014)... September 30, 2014 Hospice & ... annual “In Celebration” gala, honoring three outstanding individuals ... of striving to provide extraordinary and dignified comfort, ... a serious or life-limiting illness. , The event ... Rye, NY and recognized William (Bill) J. McGuinness, ...
(Date:9/30/2014)... Florida (PRWEB) September 30, 2014 Two revolutionary ... the treatment of gum disease a far less ... the past. , “If you’ve ever felt electric shock waves ... or sip a cold beverage, it’s possible you already know ... , who is a general dentist in West Palm Beach, ...
Breaking Medicine News(10 mins):Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:UCI study uncovers important process for immune system development 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3
... Painful endometriosis in women could be treated with a ... results of their study have been// published in the ... endometriosis have endometrial tissue developing outside the uterus, which ... a result there is often pain, bleeding, inflammation, infertility ...
... A strong warning was issued by Britain's prime minister to ... that were not-so- healthy to children or face// the risk ... that target minors. ,In a broad address on ... the voluntary regulations failing, the food industry would be forced ...
... used to get a second opinions on mammogram images, which ... slow. // ,In order to speed up the process, ... is able to get useful information from a mammogram database ... image in question to every image of breast cancer in ...
... the Albert Einstein College of Medicine of Yeshiva University ... the malaria disease by using their previous research on ... the August issue of Nature Methods, “should substantially speed ... to Dr. David Fidock, senior author of the paper ...
... experience sharp changes in their hormones once they start ... small monkeys.// ,Yevgenia Kozorovitskiy and her colleagues from ... - small monkeys that live in trees - that ... Scientist. ,The species is rare among mammals ...
... Curie Cancer Care hospice in Belfast, which has marked a major ... provisions for 18 individual en-suite rooms each of which open out ... provide for a family member to stay overnight with the patient. ... claimed that there were still more improvements to come. ...
Cached Medicine News:Health News:Google-Like Model Used To Diagnose Suspicious Breast Masses Quickly 2Health News:Malaria Truths Discovered By Einstein Researchers 2
... is a powerful magnifier that helps the partially sighted ... a hand magnifier attached to a pair of electronic ... no need for a TV set. The display is ... on a book, a can of food, a medicine ...
... vision to see objects at a distance, ... between. This battery operated system can be ... used as a desktop video magnifier when ... easy to use and requires no special ...
... general purpose incubators designed to ... and uniformity required for the ... versatile microprocessor controlled incubators feature ... easy-to-read digital display, and built-in ...
... general purpose incubators designed to ... and uniformity required for the ... versatile microprocessor controlled incubators feature ... easy-to-read digital display, and built-in ...
Medicine Products: